OWKIN dans l'actualité
Plateforme de découverte en biologie par IA
Tamtam a trouvé 20 articles récents sur OWKIN.
- Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi
- Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi
- Owkin: Pioneering Biological Artificial Superintelligence for the Future of Medicine
- Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi
- Q&A: Owkin’s five-year Sanofi deal bets on ‘purpose-built’ AI agents
- Sanofi expands AI ambitions through new Owkin collaboration
- Owkin and Sanofi Expand Partnership to Develop AI Agents Through K Pro Collaboration
- Sanofi and Owkin partner to develop next-generation biopharma AI agents
- Sanofi Owkin AI Deal Puts R&D Shift And Valuation In Focus
- Owkin To Build AI Agents As Part Of A Multi-Year K Pro Collaboration With Sanofi
- Sanofi-Owkin Expand AI Collaboration With New Agentic AI Initiative - Sanofi (NASDAQ:SNY)
- Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi
- Sanofi deepens its Owkin bet with a five-year deal to build bespoke drug-development agents
- Owkin, Sanofi expand AI collaboration to build drug development AI agents
- Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi
- Sanofi-Owkin Expand AI Collaboration With New Agentic AI Initiative
- Why AI models need patient data to deliver in drug discovery
- OWKIN Showcases AI-Driven Trial De-Risking Capabilities at Harvard Symposium
- OWKIN Highlights AI Metric Choice to Improve Oncology Target Discovery
- OWKIN Deepens U.K. Data Network and Sharpens AI Biology Strategy Amid Sector Funding Shifts
Articles collectés par Tamtam et retenus lorsqu'ils portent sur l'entreprise, des plus récents aux plus anciens. Chacun renvoie à sa source.
Vous vendez à des entreprises comme OWKIN ?
Tamtam trouve les entreprises qui correspondent à votre client idéal, analyse chaque compte et vous dit qui contacter, et quand.
Trouver des entreprises similaires